Abstract
Purpose
To evaluate the value of chest X-ray in the follow-up of surgically treated T1-3N0M0 renal cell carcinoma.
Methods
We performed retrospective analysis of patients that underwent surgical treatment of a localized renal cell carcinoma (T1-3N0M0) between January 1993 and July 2010. Data on frequency and results of performed chest X-rays were collected from patients’ records.
Results
In 17.5 years, 249 patients with a T1-3N0M0 renal cell carcinoma underwent a radical or partial nephrectomy. In 221 patients, 823 chest X-rays were performed during a median follow-up of 3.3 years (range 0.5–17 years). In 19 patients, a pulmonary recurrence occurred, of which 10 were not detected by the regular follow-up. Of the 9 patients that were diagnosed with a pulmonary recurrence with a chest X-ray during follow-up, 7 were asymptomatic at the time of diagnosis, and the chest X-ray has led to the detection; 0.85 % of the performed chest X-rays (7/823) have led to the detection of asymptomatic lung metastases.
Conclusions
Due to the low yield of chest X-ray for detection of asymptomatic pulmonary recurrences, it has very low clinical value in the follow-up after nephrectomy for T1-3N0M0 renal cell carcinoma.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin D (2008) GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet] World. Available from: http://globocan.iarc.fr
Visser O, Siesling S, van Dijck JAAM (2000) Incidence of cancer in the Netherlands 1999/2000 [Internet]. Available from: http://www.ikz.nl/uploaded/bibliotheek_upload_document/36/VIKC-Inc-2000-81-web.pdf
Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163(2):442–445
Patard J-J, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A et al (2004) Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 22(16):3316–3322
Motzer R, Bander N (1996) Renal-cell carcinoma. N Engl J 335(12):865–875
Skolarikos A, Alivizatos G, Laguna P, de la Rosette J (2007) A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 51(6):1490–1500; discussion 1501
Motzer RJ, Agarwal N, Beard C, Bhayani S, Graeme B, Carducci MA et al (2011) Kidney cancer. J Natl Compr Cancer Netw 9(9):960–977
Basu S, Biyani CS, Sundaram SK, Spencer J (2006) A survey of follow-up practice of urologists across Britain and Ireland following nephrectomy for renal cell carcinoma. Clin Radiol 61(10):854–860; discussion 861–862
Ciatto S, Pacini P, Andreoli C, Cecchini S, Iossa A, Grazzini G et al (1989) Chest X-ray survey in the follow-up of breast cancer patients. Br J Cancer 60(1):102–103
Graham RA, Wang S, Catalano PJ, Haller DG (1998) Postsurgical surveillance of colon cancer. Ann Surg 228(1):59–63
Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097
Sobin LH, Gospodarowicz M, Wittekind C (eds) (2010) International union against cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Hoboken, NJ
Landelijke werkgroep urologische tumoren (2010) Niercelcarcinoom [Internet]. pp 1–163. Available from: http://www.oncoline.nl/niercelcarcinoom
Eble JN, Epstein JI, Sesterhenn IA (2004) World health organization classification of tumours pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon
Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154(1):28–31
Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73(4):1082–1087
Hofmann H-S, Neef H, Krohe K, Andreev P, Silber R-E (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48(1):77–81; discussion 81–82
Herrmann E, Bierer S, Wülfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28(3):303–309
Molina AM, Motzer RJ (2011) Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow. Oncologist 16(Suppl 2):45–50
Levy DA, Slaton JW, Swanson DA, Dinney CP (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159(4):1163–1167
Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166(1):63–67
Lam JS, Klatte T, Kim HL, Patard J-J, Breda A, Zisman A et al (2008) Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol 65(3):235–262
Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174(2):466–472; discussion 472; quiz 801
Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW (2008) Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 179(6):2146–2151; discussion 2151
Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S et al (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60(4):644–661
Karakiewicz PI, Briganti A, Chun FK-H, Trinh Q-D, Perrotte P, Ficarra V et al (2007) Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol Off J Am Soc Clin Oncol 25(11):1316–1322
Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED et al (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671
Hupertan V, Roupret M, Poisson J-F, Chretien Y, Dufour B, Thiounn N et al (2006) Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients. Cancer 107(11):2604–2608
Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F et al (2013) Guidelines on renal cell carcinoma, update March 2013. Uroweb 2013. Available from: http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LRV2.pdf. Accesed 7 Aug 2013
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doornweerd, B.H.J., de Jong, I.J., Bergman, L.M. et al. Chest X-ray in the follow-up of renal cell carcinoma. World J Urol 32, 1015–1019 (2014). https://doi.org/10.1007/s00345-013-1176-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1176-2